Latest California Healthline Stories
Public Health Experts ‘Flabbergasted’ That Biden Still Hasn’t Picked an FDA Chief
The Food and Drug Administration has been mired in controversies related to drug approvals and covid vaccines, all without a permanent leader.
KHN’s ‘What the Health?’: Much Ado About Drug Prices
Democrats have hit a snag in their effort to compile a $3.5 trillion social-spending bill this fall — moderates are resisting support for Medicare drug price negotiation provisions that would pay for many of the measure’s health benefit improvements. Meanwhile, the new abortion restrictions in Texas have moved the divisive issue back to the political front burner. Alice Miranda Ollstein of Politico, Rachel Cohrs of Stat and Shefali Luthra of The 19th join KHN’s Julie Rovner to discuss these issues and more. Also this week, Rovner interview’s KHN’s Phil Galewitz about the latest KHN-NPR “Bill of the Month” installment, about two similar jaw surgeries with very different price tags.
Biden Releases a New Plan to Combat Covid, but Experts Say There’s Still a Ways to Go
There’s agreement that the plan includes important action items but also elements that will trigger political opposition.
Apple, Bose and Others Pump Up the Volume on Hearing Aid Options, Filling Void Left by FDA
A 2017 law designed to help lower the cost of hearing aids mandated that federal officials set rules for a new class of devices consumers could buy without needing to see an audiologist. But those regulations are still on hold.
What Missouri Learned the Hard Way About Rapid Covid Testing in Schools
Missouri’s ambitious school testing plan landed with a thud. What it can teach us now about keeping the delta variant out of classrooms.
Biden’s No-Jab-No-Job Order Creates Quandary for Nursing Homes
Nursing home operators acknowledge that large numbers of staff members are not getting the shots but fear a federal vaccination mandate could drive away workers in a tight labor market.
KHN’s ‘What the Health?’: Delta Blues
Covid is back with a vengeance, with some people clamoring for booster shots while others harden their resistance to getting vaccinated at all. Meanwhile, the Food and Drug Administration is pushing hard on drugmaker Pfizer’s request to upgrade the emergency authorization for its vaccine and give it final approval. Alice Miranda Ollstein of Politico, Rachel Cohrs of Stat and Sarah Karlin-Smith of the Pink Sheet join KHN’s Julie Rovner to discuss these issues and more. Also, for “extra credit,” the panelists suggest their favorite health policy stories of the week they think you should read, too.
At Urgent Care, He Got 5 Stitches and a Big Surprise: A Plastic Surgeon’s Bill for $1,040
The Biden administration is weighing how to treat urgent care clinics as part of broad regulations banning surprise, out-of-network medical bills. At the heart of the matter: What counts as an emergency?
KHN’s ‘What the Health?’: Delta Changes the Covid Conversation
With covid cases on the upswing again around the country, partisan division remains over how to address the pandemic. Meanwhile, the Biden administration proposes bigger penalties for hospitals that fail to make their prices public as required. Stephanie Armour of The Wall Street Journal, Alice Miranda Ollstein of Politico and Tami Luhby of CNN join KHN’s Julie Rovner to discuss these issues and more. Also, for “extra credit,” the panelists suggest their favorite stories of the week they think you should read, too.
Biden’s July Executive Order Includes Drug Pricing Provisions. But Will They Do Enough?
The July 9 directive addresses the importation of prescription drugs and broader efforts to reduce the high cost of medicines.